// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Flow Versus Pressure-Targeted Ex Vivo Heart Perfusion for Infantile Donors of Donation After Cardiac Death in Piglet Model

Junko Kobayashi - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Cardiac arrest

N/A

The Impact of a Second Arterial Conduit on Long-Term Post-Discharge Outcomes in Women and Men After Coronary Artery Bypass Grafting

Fraser Rubens - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Stroke

N/A

Interrupted Aortic Arch and Narrow Left Ventricular Outlet Tract: The Impact of Procedure Choice on Reoperation

Shuhua Luo - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Conal

Long-Term Outcomes of Endovascular Versus Open Thoracoabdominal Aortic Aneurysm Repair

Marek Ehrlich - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Myocardial infarction

N/A

Intraoperative Transit-Time Flow Measurement and High Frequency Ultrasound Assessment in Coronary Artery Bypass Grafting: Insights from the Registry for Quality Assessment (REQUEST) Study

David P. Taggart - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Should Adjuvant Therapy be Offered for Patients Undergoing Esophagectomy Post Neo-Adjuvant CROSS Protocol for Esophagectomy Cancer? A Multi-Center Cohort Study

Ronny Ben-Avi - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Solid malignancies

N/A

Low Preoperative Superior Vena Cava Blood Flow Predicts Bidirectional Cavopulmonary Shunt Failure

Shuhua Luo - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Endobronchial and Endoscopic Ultrasound-Guided Transvascular Biopsy of Mediastinal, Hilar, and Lung Lesions: Results of the First One-Hundred Consecutive Patients

Juan Carlos Molina - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Endobronchial Ultrasound Staging of Operable NSCLC: Triple Negative Lymph Nodes May Not Require Routine Biopsy

Danielle Hylton - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

Patient-Derived Esophageal Adenocarcinoma Organoids Recapitulate the Primary Tumor

Mathieu Derouet - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Esophageal Cancer

noggin

Is Surgical Repair of Anomalous Aortic Origin of a Coronary Artery Benign?

Anusha Jegatheeswaran - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Anomalous aortic origin of a coronary artery

N/A

Lung Transplantation Using Older Donors - Further Extending the Criteria: A Retrospective Cohort Study

Ben Dunne - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

The Learning Curve on Uniportal Video-Assisted Thoracic Surgery for Early Stage Lung Cancer: A Follow-Up Analysis on Proficiency

Arthur Vieira - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Lung Cancer

N/A

The VTE PRO: A Double Blind, Randomized Control Trial Comparing Extended, Post-Discharge Venous Thromboembolic Events Prophylaxis with Placebo in Patients Undergoing Major Oncological Lung Resections

Yaron Shargall - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

Heparin

Surgical Valve Selection in Aortic Valve Replacement in the Era of Transcatheter Aortic Valve Replacement

Derrick Tam - American Association for Thoracic Surgery (AATS) , 2019

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

MON-325 Co-Occurrence of Breast Cancer and Neuroendocrine Tumors: More Than a Coincidence?

Vincent Larouche - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Genetic Disorder

N/A

Capecitabine

SAT-326 INPP4B Suppresses Prostate Inflammation And Protects Mice Fed With High-fat Diet From The Development Of Prostate Intraepithelial Neoplasia

Manqi Zhang - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

Androgen Tear

SAT-318 A Case of Metastatic Paraganglioma

Manijeh Mohammadi - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

Octreotide

OR19-4 High Prevalence of Primary Hypothyroidism in Patients with Alkaptonuria Eighteen Years of Experience

Shirisha Avadhanula - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Hypothyroidism

Levothyroxine

SUN-573 Plasmapheresis in Thyroid storm

Riham Elmahboubi - Endocrine Society (ENDO) , 2019

Therapeutic Area

Disease

Drug/Treatment

Congenital disorder

Arrhythmia

Propylthiouracil

Copyright © 2026. QuantiNova All rights reserved